Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy

Neural Plasticity

Volumn 2012, Issue , 2012, Pages

  Juárez, Paula ^a,b   Palau, Francesc ^a,b,c  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Universidad de Castilla La Mancha   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; ASCORBIC ACID; CURCUMIN; HEAT SHOCK PROTEIN 22; HEAT SHOCK PROTEIN 27; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 6 INHIBITOR; HISTONE DEACETYLASE INHIBITOR; MYELIN; NEU DIFFERENTIATION FACTOR; NEUROTROPHIC FACTOR; ONAPRISTONE; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CELL INTERACTION; CELL MEMBRANE; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOLOGY; DISEASE SEVERITY; ENDOPLASMIC RETICULUM; ENDOSOME; GENE MUTATION; GENE THERAPY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MICROTUBULE; MOTOR NEUROPATHY; MUSCLE ATROPHY; MYELINATION; NERVE CELL PLASTICITY; NERVE FIBER; NERVE FIBER TRANSPORT; NERVE REGENERATION; NEUROFILAMENT; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIPHERAL NERVE; PHENOTYPE; PHENOTYPIC VARIATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SCHWANN CELL; SENSORY NEUROPATHY; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TRANSCRIPTION REGULATION; X CHROMOSOME LINKED DISORDER;

EID: 84863752359     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2012/171636     Document Type: Review

References (113)

1. Skre H., Genetic and clinical aspects of Charcot Marie Tooth's disease Clinical Genetics 1974 6 2 98 118
2. Combarros O., Calleja J., Polo J. M., Berciano J., Prevalence of hereditary motor and sensory neuropathy in Cantabria Acta Neurologica Scandinavica 1987 75 1 9 12 (Pubitemid 17027274)
3. Lupski J. R., Garcia C. A., Scriver C. R., Beaudet A. L., Sly W. S., Valle D., Childs B., Kinzler K. W., Vogelstein B., Charcot-Marie-Tooth peripheral neuropathies and related disorders The Metabolic and Molecular Bases of Inherited Disease 2000 8th New York, NY, USA McGraw-Hill 5759 5788
4. Szigeti K., Lupski J. R., Rimoin R. L., Connor J. M., Pyeritz R. E., Korf B. R., Hereditary motor and sensory neuropathies Emory and Rimoins Principles and Practice of Medical Genetics 2007 5th Philadelphia, Pa, USA Churchill Livingstone Elsevier 2946 2962
5. Patzk A., Shy M. E., Update on Charcot-Marie-Tooth disease Current Neurology and Neuroscience Reports 2011 11 1 78 88
6. Krajewski K. M., Lewis R. A., Fuerst D. R., Turansky C., Hinderer S. R., Garbern J., Kamholz J., Shy M. E., Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A Brain 2000 123 7 1516 1527 (Pubitemid 30420950)
7. Pareyson D., Scaioli V., Laur M., Clinical and electrophysiological aspects of charcot-marie-tooth disease NeuroMolecular Medicine 2006 8 1-2 3 22
8. Scherer S. S., Wrabetz L., Molecular mechanisms of inherited demyelinating neuropathies Glia 2008 56 14 1578 1589
9. Mirsky R., Jessen K. R., The neurobiology of Schwann cells Brain Pathology 1999 9 2 293 311 (Pubitemid 29157717)
10. Webster H., De F., Dyck P. J., Thomas P. K., Griffin J. W., Low P. A., Poduslo J. F., Development of peripheral nerve fibres Peripheral Neuropathy 1993 3th Philadelphia, Pa, USA WB Saunders 243 266
11. Corfas G., Velardez M. O., Ko C. P., Ratner N., Peles E., Mechanisms and roles of axon-Schwann cell interactions Journal of Neuroscience 2004 24 42 9250 9260 (Pubitemid 39426161)
12. Corfas G., Rosen K. M., Aratake H., Krauss R., Fischbach G. D., Differential expression of ARIA isoforms in the rat brain Neuron 1995 14 1 103 115
13. Meyer D., Birchmeier C., Multiple essential functions of neuregulin in development Nature 1995 378 6555 386 390
14. Perlin J. R., Lush M. E., Stephens W. Z., Piotrowski T., Talbot W. S., Neuronal Neuregulin 1 type III directs Schwann cell migration Development 2011 138 4639 4648
15. De Waegh S., Brady S. T., Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for schwann cell-axon interactions Journal of Neuroscience 1990 10 6 1855 1865
16. Massicote C., Scherer S. S., Waxman S. G., Neuropathies-translating causes into treatments Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology 2004 London, UK Elsevier Science 401 414
17. Shy M. E., Biology of peripheral inherited neuropathies: schwann cell axonal interactions Advances in Experimental Medicine and Biology 2009 652 171 181
18. Zchner S., Vance J. M., Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies Nature Clinical Practice Neurology 2006 2 1 45 53
19. Sevilla T., Jaijo T., Nauffal D., Collado D., Chumillas M. J., Vilchez J. J., Muelas N., Bataller L., Domenech R., Espins C., Palau F., Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy Brain 2008 131 11 3051 3061
20. Pareyson D., Marchesi C., Diagnosis, natural history, and management of Charcot-Marie-Tooth disease The Lancet Neurology 2009 8 7 654 667
21. Berciano J., Garca A., Gallardo E., Ramn C., Combarros O., Phenotype and clinical evolution of charcot-marie-tooth disease type 1A duplication Advances in Experimental Medicine and Biology 2009 652 183 200
22. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A., Chakravarti A., Patel P. I., DNA duplication associated with Charcot-Marie-Tooth disease type 1A Cell 1991 66 2 219 232 (Pubitemid 121001361)
23. Raeymaekers P., Timmerman V., Nelis E., De Jonghe P., Hoogendijk J. E., Baas F., Barker D. F., Martin J. J., De Visser M., Bolhuis P. A., Van Broeckhoven C., Ceuterick C., De Winter G., Denayer P., Gheuens J., Jacobs K., Mercelis R., Raes G., Ringoet K., Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) Neuromuscular Disorders 1991 1 2 93 97
24. Chance P. F., Alderson M. K., Leppig K. A., Lensch M. W., Matsunami N., Smith B., Swanson P. D., Odelberg S. J., Disteche C. M., Bird T. D., DNA deletion associated with hereditary neuropathy with liability to pressure palsies Cell 1993 72 1 143 151 (Pubitemid 23029701)
25. Chance P. F., Abbas N., Lensch M. W., Pentao L., Roa B. B., Patel P. I., Lupski J. R., Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17 Human Molecular Genetics 1994 3 2 223 228 (Pubitemid 24060934)
26. Nicholson G. A., Valentijn L. J., Cherryson A. K., Kennerson M. L., Bragg T. L., DeKroon R. M., Ross D. A., Pollard J. D., Mcleod J. G., Bolhuis P. A., Baas F., A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies Nature Genetics 1994 7 1 113 (Pubitemid 24232393)
27. Bort S., Nelis E., Timmerman V., Sevilla T., Cruz-Martnez A., Martnez F., Milln J. M., Arpa J., Vlchez J. J., Prieto F., Van Broeckhoven C., Palau F., Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies Human Genetics 1997 99 6 746 754 (Pubitemid 27243752)
28. Lupski J. R., Chance P. F., Dyck P. L., Thomas P. K., Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: the CMT1A duplication and HNPP deletion Peripheral Neuropathy 2005 4th Philadelphia, Pa, USA Elsevier Saunders 1659 1680
29. Infante J., Garca A., Combarros O., Mateo J. I., Berciano J., Sedano M. J., Gutiérrez-Rivas E. J., Palau F., Diagnostic strategy for familial and sporadic cases of neuropathy associated with 17p11.2 deletion Muscle and Nerve 2001 24 9 1149 1155 (Pubitemid 32762142)
30. Fortun J., Go J. C., Li J., Amici S. A., Dunn W. A. Jr., Notterpek L., Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression Neurobiology of Disease 2006 22 1 153 164
31. Fortun J., Dunn W. A. Jr., Joy S., Li J., Notterpek L., Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells Journal of Neuroscience 2003 23 33 10672 10680 (Pubitemid 37485281)
32. Fortun J., Verrier J. D., Go J. C., Madorsky I., Dunn W. A. Jr., Notterpek L., The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones Neurobiology of Disease 2007 25 2 252 265 (Pubitemid 46124007)
33. Aldkofer K., Naef R., Suter U., Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele Journal of Neuroscience Research 1997 49 671 680 (Pubitemid 27430167)
34. Eylar E. H., Uyemura K., Brostoff S. W., Proposed nomenclature for PNS myelin proteins Neurochemical Research 1979 4 2 289 293 (Pubitemid 9244371)
35. Greenfield S., Brostoff S., Eylar E. H., Morell P., Protein composition of myelin of the peripheral nervous system Journal of Neurochemistry 1973 20 4 1207 1216
36. Shy M. E., Jni A., Krajewski K., Grandis M., Lewis R. A., Li J., Shy R. R., Balsamo J., Lilien J., Garbern J. Y., Kamholz J., Phenotypic clustering in MPZ mutations Brain 2004 127 2 371 384 (Pubitemid 38160322)
37. Nave K. A., Sereda M. W., Ehrenreich H., Mechanisms of disease: inherited demyelinating neuropathiesFrom basic to clinical research Nature Clinical Practice Neurology 2007 3 8 453 464 (Pubitemid 47202502)
38. Pennuto M., Tinelli E., Malaguti M., Del Carro U., D'Antonio M., Ron D., Quattrini A., Feltri M. L., Wrabetz L., Ablation of the UPR-Mediator CHOP Restores MotorFunction and Reduces Demyelination inCharcot-Marie-Tooth 1B Mice Neuron 2008 57 3 393 405 (Pubitemid 351179164)
39. Maeda M. H., Mitsui J., Soong B. W., Takahashi Y., Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease Annals of Neurology 2012 71 84 92
40. Pareyson D., Axonal Charcot-Marie-Tooth disease: the fog is only slowly lifting Neurology 2007 68 20 1649 1650 (Pubitemid 46763250)
41. Verhoeven K., Claeys K. G., Zchner S., Schrder J. M., Weis J., Ceuterick C., Jordanova A., Nelis E., De Vriendt E., Van Hul M., Seeman P., Mazanec R., Saifi G. M., Szigeti K., Mancias P., Butler I. J., Kochanski A., Ryniewicz B., De Bleecker J., Van Den Bergh P., Verellen C., Van Coster R., Goemans N., Auer-Grumbach M., Robberecht W., Milic Rasic V., Nevo Y., Tournev I., Guergueltcheva V., Roelens F., Vieregge P., Vinci P., Moreno M. T., Christen H. J., Shy M. E., Lupski J. R., Vance J. M., De Jonghe P., Timmerman V., MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2 Brain 2006 129 8 2093 2102 (Pubitemid 44289074)
42. Chan D. C., Dissecting mitochondrial fusion Developmental Cell 2006 11 5 592 594 (Pubitemid 44644971)
43. Okamoto K., Shaw J. M., Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes Annual Review of Genetics 2005 39 503 536 (Pubitemid 43011125)
44. De Brito O. M., Scorrano L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria Nature 2008 456 7222 605 610
45. Bach D., Pich S., Soriano F. X., Vega N., Baumgartner B., Oriola J., Daugaard J. R., Lloberas J., Camps M., Zierath J. R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacn M., Vidal H., Rivera F., Brand M., Zorzano A., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity Journal of Biological Chemistry 2003 278 19 17190 17197 (Pubitemid 36799599)
46. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H. W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., Hirokawa N., Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B Cell 2001 105 5 587 597 (Pubitemid 32524112)
47. Chen H., McCaffery J. M., Chan D. C., Mitochondrial fusion protects against neurodegeneration in the cerebellum Cell 2007 130 3 548 562 (Pubitemid 47198302)
48. Detmer S. A., Chan D. C., Functions and dysfunctions of mitochondrial dynamics Nature Reviews Molecular Cell Biology 2007 8 11 870 879 (Pubitemid 47622562)
49. Detmer S. A., Velde C. V., Cleveland D. W., Chan D. C., Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A Human Molecular Genetics 2008 17 3 367 375
50. Cartoni R., Arnaud E., Médard J. J., Poirot O., Courvoisier D. S., Chrast R., Martinou J. C., Expression of mitofusin 2R94Q in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A Brain 2010 133 5 1460 1469
51. Misko A., Jiang S., Wegorzewska I., Milbrandt J., Baloh R. H., Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex Journal of Neuroscience 2010 30 12 4232 4240
52. Lupski J. R., Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF- L) American Journal of Human Genetics 2000 67 1 8 10 (Pubitemid 30481538)
53. Gentil B. J., Minotti S., Beange M., Baloh R. H., Julien J. P., Durham H. D., Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease The FASEB Journal 2011 26 3 1194 1203
54. Dequen F., Filali M., Larivire R. C., Perrot R., Hisanaga S. I., Julien J. P., Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E Human Molecular Genetics 2010 19 13 2616 2629
55. Hahn A. F., Brown W. F., Koopman W. J., Feasby T. E., X-linked dominant hereditary motor and sensory neuropathy Brain 1990 113 5 1511 1525 (Pubitemid 20385928)
56. Bergoffen J., Scherer S. S., Wang S., Oronzi Scott M., Bone L. J., Paul D. L., Chen K., Lensch M. W., Chance P. F., Fischbeck K. H., Connexin mutations in X-linked Charcot-Marie-Tooth disease Science 1993 262 5142 2039 2042 (Pubitemid 24041884)
57. Vital A., Ferrer X., Lagueny A., Vandenberghe A., Latour P., Goizet C., Canron M. H., Louiset P., Petry K. G., Vital C., Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations Journal of the Peripheral Nervous System 2001 6 2 79 84 (Pubitemid 32606888)
58. Anzini P., Neuberg D. H.-H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K. V., Suter U., Martini R., Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32 Journal of Neuroscience 1997 17 12 4545 4551 (Pubitemid 27246912)
59. Baxter R. V., Othmane K. B., Rochelle J. M., Stajich J. E., Hulette C., Dew-Knight S., Hentati F., Hamida M. B., Bel S., Stenger J. E., Gilbert J. R., Pericak-Vance M. A., Vance J. M., Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 Nature Genetics 2002 30 1 21 22
60. Cuesta A., Pedrola L., Sevilla T., Garca-Planells J., Chumillas M. J., Mayordomo F., LeGuern E., Marn I., Vlchez J. J., Palau F., The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease Nature Genetics 2002 30 1 22 25
61. Claramunt R., Pedrola L., Sevilla T., Lpez De Munain A., Berciano J., Cuesta A., Snchez-Navarro B., Milln J. M., Saifi G. M., Lupski J. R., Vlchez J. J., Espins C., Palau F., Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect Journal of Medical Genetics 2005 42 4 358 365 (Pubitemid 40523959)
62. Marco A., Cuesta A., Pedrola L., Palau F., Marn I., Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes Molecular Biology and Evolution 2004 21 1 176 187 (Pubitemid 38233531)
63. Pedrola L., Espert A., Wu X., Claramunt R., Shy M. E., Palau F., GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria Human Molecular Genetics 2005 14 8 1087 1094 (Pubitemid 40575884)
64. Pedrola L., Espert A., Valdés-Snchez T., Snchez-Piris M., Sirkowski E. E., Scherer S. S., Farias I., Palau F., Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease Journal of Cellular and Molecular Medicine 2008 12 2 679 689 (Pubitemid 351555145)
65. Niemann A., Ruegg M., La Padula V., Schenone A., Suter U., Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease Journal of Cell Biology 2005 170 7 1067 1078 (Pubitemid 41362639)
66. Palau F., Estela A., Pla-Martn D., Snchez-Piris M., The role of mitochondrial network dynamics in the pathogenesis of charcot-marie-tooth disease Advances in Experimental Medicine and Biology 2009 652 129 137
67. Niemann A., Wagner K. M., Ruegg M., Suter U., GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance Neurobiology of Disease 2009 36 3 509 520
68. Estela A., Pla-Martn D., Snchez-Piris M., Sesaki H., Palau F., The Charcot-Marie-Tooth related gene GDAP1 complements cell cycle delay at G2/M in S. cerevisiae fis1 defective cells Journal of Biological Chemistry 2011 286 36777 36786
69. Kalaydjieva L., Lochmller H., Tournev I., 125th ENMC International Workshop: Neuromuscular disorders in the Roma (Gypsy) population, p. 23, April 2004, Naarden, The Netherlands Neuromuscular Disorders 2005 15 1 65 71 (Pubitemid 41556635)
70. Colomer J., Gooding R., Angelicheva D., King R. H., Guillén- Navarro E., Parman Y., Nascimento A., Conill J., Kalaydjieva L., Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2 Neuromuscular Disorders 2006 16 7 449 453 (Pubitemid 44094101)
71. Claramunt R., Sevilla T., Lupo V., Cuesta A., Milln J. M., Vlchez J. J., Palau F., Espins C., The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4 Clinical Genetics 2007 71 4 343 349 (Pubitemid 46680799)
72. Arnaud E., Zenker J., de Preux Charles A. S., Stendel C., Roos A., Médard J. J., Tricaud N., Weis J., Suter U., Senderek J., Chrast R., SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system Proceedings of the National Academy of Sciences of the United States of America 2009 106 41 17528 17533
73. Lupo V., Galindo M. I., Martnez-Rubio D., Sevilla T., Vlchez J. J., Palau F., Espins C., Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway Human Molecular Genetics 2009 18 23 4603 4614
74. Roberts R. C., Peden A. A., Buss F., Bright N. A., Latouche M., Reilly M. M., Kendrick-Jones J., Paul Luzio J., Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C Human Molecular Genetics 2009 19 6 1009 1018
75. Stendel C., Roos A., Kleine H., Arnaud E., zelik M., Sidiropoulos P. N. M., Zenker J., Schpfer F., Lehmann U., Sobota R. M., Litchfield D. W., Lscher B., Chrast R., Suter U., Senderek J., SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling Brain 2010 133 8 2462 2474
76. Baloh R. H., Mitochondrial dynamics and peripheral neuropathy Neuroscientist 2008 14 1 12 18
77. Sahenk Z., Neurotrophins and peripheral neuropathies Brain Pathology 2006 16 4 311 319
78. Hoffman P. N., Lasek R. J., Axonal transport of the cytoskeleton in regenerating motor neurons: constancy and change Brain Research 1980 202 2 317 333 (Pubitemid 11130317)
79. McQuarrie I. G., Lasek R. J., Transport of cytoskeletal elements from parent axons into regenerating daughter axons Journal of Neuroscience 1989 9 2 436 446 (Pubitemid 19069487)
80. Verma P., Chierzi S., Codd A. M., Campbell D. S., Meyer R. L., Holt C. E., Fawcett J. W., Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration Journal of Neuroscience 2005 25 2 331 342 (Pubitemid 40105603)
81. Willis D. E., Twiss J. L., The evolving roles of axonally synthesized proteins in regeneration Current Opinion in Neurobiology 2006 16 1 111 118 (Pubitemid 43221861)
82. Navarro X., Viv M., Valero-Cabré A., Neural plasticity after peripheral nerve injury and regeneration Progress in Neurobiology 2007 82 4 163 201 (Pubitemid 47088051)
83. Perea J., Robertson A., Tolmachova T., Muddle J., King R. H. M., Ponsford S., Thomas P. K., Huxley C., Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A Human Molecular Genetics 2001 10 10 1007 1018 (Pubitemid 32447778)
84. Passage E., Norreel J. C., Noack-Fraissignes P., Sanguedolce V., Pizant J., Thirion X., RobaGlia-Schlupp A., Pellissier J. F., Fontés M., Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease Nature Medicine 2004 10 4 396 401 (Pubitemid 38508518)
85. Kaya F., Belin S., Bourgeois P., Micaleff J., Blin O., Fontés M., Ascorbic acid inhibits PMP22 expression by reducing cAMP levels Neuromuscular Disorders 2007 17 3 248 253 (Pubitemid 46420772)
86. Pareyson D., Reilly M. M., Schenone A., Fabrizi G. M., Cavallaro T., Santoro L., Vita G., Quattrone A., Padua L., Gemignani F., Visioli F., Laur M., Radice D., Calabrese D., Hughes R. A. C., Solari A., Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial The Lancet Neurology 2011 10 4 320 328
87. Désarnaud F., Do Thi A. N., Brown A. M., Lemke G., Suter U., Baulieu E. E., Schumacher M., Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells Journal of Neurochemistry 1998 71 4 1765 1768 (Pubitemid 28443052)
88. Sereda M. W., Meyer zu Hrste G., Suter U., Uzma N., Nave K. A., Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) Nature Medicine 2003 9 12 1533 1537 (Pubitemid 38004782)
89. zu Horste G. M., Prukop T., Liebetanz D., Mobius W., Nave K. A., Sereda M. W., Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy Annals of Neurology 2007 61 1 61 72 (Pubitemid 46214245)
90. Khajavi M., Shiga K., Wiszniewski W., He F., Shaw C. A., Yan J., Wensel T. G., Snipes G. J., Lupski J. R., Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy American Journal of Human Genetics 2007 81 3 438 453 (Pubitemid 47330204)
91. d'Ydewalle C., Krishnan J., Chiheb D. M., Van Damme P., Irobi J., Kozikowski A. P., Berghe P. V., Timmerman V., Robberecht W., Van Den Bosch L., HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease Nature Medicine 2011 17 8 968 974
92. Soragni E., Xu C., Cooper A., Plasterer H. L., Rusche J. R., Gottesfeld J. M., Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases Methods Molecular Biology 2011 793 495 508
93. Verd E., Navarro X., Castellano B., Gonzlez B., Nieto Sampedro M., The role of Schwann cell in nerve regeneration Understanding Glial Cells 1998 Boston, Mass, USA Kluwer Academic 319 359
94. Chen L. E., Liu K., Seaber A. V., Katragadda S., Kirk C., Urbaniak J. R., Recombinant human Glial growth factor 2 (rhGGF 2) improves functional recovery of crushed peripheral nerve (a double-blind study) Neurochemistry International 1998 33 4 341 351 (Pubitemid 28529512)
95. Birchmeier C., Nave K. A., Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation Glia 2008 56 14 1491 1497
96. Newbern J., Birchmeier C., Nrg1/ErbB signaling networks in Schwann cell development and myelination Seminars in Cell and Developmental Biology 2010 21 9 922 928
97. Sahenk Z., Nagaraja H. N., McCracken B. S., King W. M., Freimer M. L., Cedarbaum J. M., Mendell J. R., NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients Neurology 2005 65 5 681 689 (Pubitemid 41285845)
98. Bibel M., Barde Y. A., Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system Genes and Development 2000 14 23 2919 2937
99. Funakoshi H., Risling M., Carlstedt T., Lendahl U., Timmusk T., Metsis M., Yamamoto Y., Ibez C. F., Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 5269 5274 (Pubitemid 28208587)
100. Haastert K., Grothe C., Gene therapy in peripheral nerve reconstruction approaches Current Gene Therapy 2007 7 3 221 228 (Pubitemid 46902204)
101. Zacchigna S., Giacca M., Chapter 20 gene therapy perspectives for nerve repair International Review of Neurobiology 2009 87 381 392
102. Homs J., Ariza L., Pags G., Udina E., Navarro X., Chilln M., Bosch A., Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration Gene Therapy 2011 18 6 622 630
103. Kirchmair R., Tietz A. B., Panagiotou E., Walter D. H., Silver M., Yoon Y. S., Schratzberger P., Weber A., Kusano K., Weinberg D. H., Ropper A. H., Isner J. M., Losordo D. W., Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF Molecular Therapy 2007 15 1 69 75 (Pubitemid 46043651)
104. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., Freeman T. B., Saporta S., Janssen W., Patel N., Cooper D. R., Sanberg P. R., Adult bone marrow stromal cells differentiate into neural cells in vitro Experimental Neurology 2000 164 2 247 256 (Pubitemid 32008970)
105. Kokai L. E., Rubin J. P., Marra K. G., The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells Plastic and Reconstructive Surgery 2005 116 5 1453 1460 (Pubitemid 41456527)
106. Caddick J., Kingham P. J., Gardiner N. J., Wiberg M., Terenghi G., Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage Glia 2006 54 8 840 849 (Pubitemid 44671989)
107. Tohill M., Mantovani C., Wiberg M., Terenghi G., Rat bone marrow mesenchymal stem cells express Glial markers and stimulate nerve regeneration Neuroscience Letters 2004 362 3 200 203 (Pubitemid 38648941)
108. Keilhoff G., Goihl A., Langnse K., Fansa H., Wolf G., Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells European Journal of Cell Biology 2006 85 1 11 24 (Pubitemid 43055554)
109. Safford K. M., Hicok K. C., Safford S. D., Halvorsen Y. D. C., Wilkison W. O., Gimble J. M., Ricea H. E., Neurogenic differentiation of murine and human adipose-derived stromal cells Biochemical and Biophysical Research Communications 2002 294 2 371 379 (Pubitemid 34694105)
110. Zuk P. A., Zhu M., Ashjian P., De Ugarte D. A., Huang J. I., Mizuno H., Alfonso Z. C., Fraser J. K., Benhaim P., Hedrick M. H., Human adipose tissue is a source of multipotent stem cells Molecular Biology of the Cell 2002 13 12 4279 4295 (Pubitemid 35471185)
111. Kingham P. J., Kalbermatten D. F., Mahay D., Armstrong S. J., Wiberg M., Terenghi G., Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro Experimental Neurology 2007 207 2 267 274 (Pubitemid 47432883)
112. Mantovani C., Mahay D., Kingham M., Terenghi G., Shawcross S. G., Wiberg M., Bone marrow- and adipose-derived stem cells show expression of myelin mRNAs and proteins Regenerative Medicine 2010 5 3 403 410
113. Di Summa P. G., Kingham P. J., Raffoul W., Wiberg M., Terenghi G., Kalbermatten D. F., Adipose-derived stem cells enhance peripheral nerve regeneration Journal of Plastic, Reconstructive and Aesthetic Surgery 2010 63 9 1544 1552